David Gardner, an early investor in Tesla and Nvidia, on how to pick individual stocks in the era of index investing 

How an investor can find the new Netflix or Amazon: 6 principles from the founder of The Motley Fool

Odyssey Therapeutics

Preliminary trading in shares of biotech Odyssey Therapeutics, which develops drugs for the treatment of autoimmune and inflammatory diseases, began in the trading system for Freedom clients. Later on Ma. 8, the company's securities will appear on the Nasdaq under the ticker <a href="https://freedom24.com/terminal?ticker=ODTX.US&amp;utm_source=stocks&amp;utm_medium=ODTX.US&amp;utm_campaign=pfu18121435">ODTX</a>.

Odyssey IPO: shares of biotech with a novel approach to autoimmune diseases began trading

Mobia Medical

Preliminary trading in shares of Mobia Medical, a manufacturer of medical devices for rehabilitation of patients after stroke, has started in the trading system for Freedom clients. The company's flagship solution is the Vivistim system, an implantable vagus nerve stimulation device that helps chronic ischemic stroke patients regain motor function through neuroplasticity in the brain. Later on Ma. 8, Mobia Medical's securities will appear on the Nasdaq under the ticker <a href="https://tap.freedom24.com/to/quote/MOBI.US?utm_source=stocks&amp;utm_medium=MOBI.US&amp;utm_campaign=pfu18121435">MOBI</a>.

Mobia Medical IPO: developer of stroke rehabilitation systems goes public

iQIYI, Inc.

Chinese streaming service iQiyi, which operates on the principle of Netflix, has figured out how to overcome years of sales decline. In five years, most of its movies and TV series will be created using artificial intelligence, <a href="https://www.bloomberg.com/news/articles/2026-04-20/china-s-netflix-iqiyi-goes-all-in-on-ai-content-in-big-overhaul?embedded-checkout=true">said</a> Yu Gong, the company's founder and CEO. This will be a monumental shift in the industry and will push iQiyi into its biggest reorganization since it was founded in 2010, Bloomberg <a href="https://www.bloomberg.com/news/articles/2026-04-20/china-s-netflix-iqiyi-goes-all-in-on-ai-content-in-big-overhaul?embedded-checkout=true">writes </a>. Wall Street projects the "Chinese Netflix" to grow 950%.

With the prospect of 10x growth: how AI has become a major bet for iQiyi's "China's Netflix"

The funding for one of the world's leading AI companies came from a Series F round of funding

The National Bank of Kazakhstan became an investor in AI company Anthropic

CoreWeave, Inc.

The analyst compared the company's strategy to the formation of Amazon

CoreWeave shares plummet: revenue doubles, but rising AI chip costs hit margins

DoubleLine Capital founder Jeffrey Gundlach, known as the "bond king," is rearranging positions in his portfolios in case of an "extreme" scenario in which the U.S. could go for a debt restructuring in response to a potential recession, Bloomberg <a href="https://www.bloomberg.com/news/articles/2026-05-08/gundlach-takes-longshot-bet-on-us-debt-revamp-with-low-coupons">writes.</a>

"Bond king" allowed an "extreme" scenario for the US. How does he change his portfolio?

Cloudflare, Inc.

A US court has ruled Donald Trump's 10 percent duties illegal. The escalation of the conflict between the US and Iran in the Strait of Hormuz pushed oil back above $100. These and other topics are in our review of key events for the morning of Ma 8.

Highlights for this morning: Trump's duties ruled illegal, U.S. and Iran exchange strikes

Data

BlackSky Technology Inc.

Redwire Corporation

Voyager Technologies, Inc.

SYNSPECTIVE INC

Expectations for a potential IPO by SpaceX have become a driver for the broader space sector. Elon Musk’s company has <a href="https://www.bloomberg.com/news/articles/2026-04-02/spacex-is-said-to-target-more-than-2-trillion-valuation-in-ipo#selection-2487.168-2487.223">raised</a>&nbsp;its target valuation to more than $2 trillion as it prepares investor presentations ahead of a potential IPO, Bloomberg reports, citing people familiar with the matter. The listing is expected this summer, with SpaceX potentially raising as much as $75 billion, which would make it one of the largest market debuts ever. Below, analyst Aldiyar Anuarbekov has picked five publicly traded space small caps for&nbsp;<i>Oninvest </i>that give investors exposure to the sector ahead of SpaceX’s expected IPO. The names specialize in satellite intelligence, radar imaging, infrastructure, and defense tech.

Five small caps for investing in the space sector ahead of the SpaceX IPO

Beyond Meat, Inc.

Shares of Beyond Meat has&nbsp;<a href="https://finance.yahoo.com/quote/BYND/">plunged</a>&nbsp;12.5% in extended trading after the plant-based meat producer <a href="https://investors.beyondmeat.com/news-releases/news-release-details/beyond-meatr-reports-first-quarter-2026-financial-results">reported</a>&nbsp;that its net revenue fell more than 15% year over year in the first quarter. The company also warned that the figure could decline even further in the second.

Beyond Meat sinking on weak forecast second-quarter sales amid sluggish demand

HawkEye 360

Pre-IPO trading in shares of HawkEye 360, a company that provides government customers with intelligence and analytics data based on radio-frequency signals collected from space, has started on Freedom’s client trading platform. Later on Thursday, the company’s shares will debut on the New York Stock Exchange under the ticker <a href="https://tap.freedom24.com/to/quote/HAWK.US?utm_source=stocks&amp;utm_medium=HAWK.US&amp;utm_campaign=pfu18121435">HAWK</a>.

HawkEye 360 IPO: Surveillance firm debuts on the NYSE

Lucid Group, Inc.

Shares of EV maker Lucid Group are down nearly 5% in premarket trading on Wednesday after the company <a href="https://ir.lucidmotors.com/news-releases/news-release-details/lucid-announces-first-quarter-2026-financial-results">reported</a>&nbsp;first-quarter results. Its quarterly revenue rose 20% year over year, but it still came in <a href="https://www.barrons.com/articles/lucid-stock-price-earnings-744d1f2f?mod=RTA">well below Wall Street expectations</a>. Lucid also <a href="https://finance.yahoo.com/sectors/technology/articles/lucid-motors-doesn-t-know-223157667.html">withdrew</a>&nbsp;its vehicle production guidance for 2026.

EV maker Lucid sliding on wider-than-expected 1Q loss

Assertio Holdings, Inc.

Shares of micro-cap oncology and neurology drugmaker <a href="https://investor.assertiotx.com/overview/default.aspx">Assertio Holdings</a>&nbsp;<a href="https://finance.yahoo.com/quote/ASRT/">surged</a>&nbsp;17% on Monday to hit a multiyear high after the company <a href="https://investor.assertiotx.com/news/news-details/2026/Assertio-Announces-Amended-and-Restated-Merger-Agreement-with-Garda-Therapeutics/default.aspx">said</a>&nbsp;Garda Therapeutics had agreed to pay 21% more for it than initially <a href="https://investor.assertiotx.com/news/news-details/2026/Assertio-Announces-Agreement-to-be-Acquired-by-Garda-Therapeutics/default.aspx">planned</a>&nbsp;just a month ago. Assertio said the increase followed the receipt of a superior acquisition proposal.

Micro-cap drugmaker Assertio jumps 17% after Garda sweetens takeover bid

Small Caps

Important news and analysis of global stock markets, plus crypto, bonds, and ETFs

Investment and Finance News